At Nairobi, Kenya, on Tuesday, the 26th of October, 2021, Moderna (a biotechnology company in Norwood, Massachusetts, U.S.) declared that they will provide Covid-19 vaccines of 110 million doses to countries in Africa. The effort was made possible by the United States.
Since Africa has the most unvaccinated persons globally, industry leaders describe Moderna’s exertion as a welcome development.
The biotechnology company says that before 2021 runs out, they will supply the first 15 million doses. They further said they would send 35 million doses by the 2022s first quarter, with the last dose of 60 million sent by the ending of June.
The company says they will send the vaccines at the lowest prices possible. The undertaking to supply the vaccine is in line with the company’s promise of shipping 500 million doses of the COVAX program by 2022.
Jen Psaki, the U.S. press secretary, says in line with the announcement that they will postpone the plan to supply 33 million Covid-19 doses to Americans for Africans to receive theirs.
In Africa, health unions plan to vaccinate 450 million persons by September 2022. They signed a contract to supply 400 million doses by Johnson & Johnson (a holding company in New Jersey that develops, researches, and manufactures healthcare products).
However, if the Moderna contract becomes real, African Union can attain its primary goal.
GAVI’s Seth Berkley regretted that of the 1.3 billion Africans that less than 9% persons had had their first dose.